Sallin Aymeric has filed 10 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 178000 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 02, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | A | Common Stock | 178000 | $0.00 | 178,000.0000 | 5,397,597 | 9999.99% | 3.30% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.13% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | D | Stock Option (Right to Buy) | 75000 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.47% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Sallin Aymeric | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |